MDHHS Recommends Providers Resume Johnson & Johnson COVID-19 Vaccination

Following the decision by U.S. health officials to lift the pause on the Johnson & Johnson COVID-19 vaccination on Friday, the Michigan Department of Health and Human Services is recommending vaccine providers across the state resume the use of the vaccine to vaccinate Michiganders age 18 and older.

“We are glad to be able to begin administering the Johnson & Johnson vaccine again in Michigan following the thorough review and recommendations of ACIP, CDC and FDA,” said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health. “This brief pause indicates there is a robust safety review process in place for these vaccines. These adverse events appear to be extremely rare as nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the U.S. with only 15 cases of this blood clotting syndrome confirmed. We encourage everyone to continue making appointments to be vaccinated with the safe and effective Johnson & Johnson, Pfizer and Moderna COVID-19 vaccines. These vaccines are the way we are going to end this pandemic as quickly as possible and move toward a sense of normalcy.”

The vaccine’s rollout had been on pause for more than a week after a small percentage of people experienced rare blood clots.

So far, the CDC knows of 15 American women who developed blood clots linked to the vaccine. Three of them have died and seven remain hospitalized. During clinical trials, one man experienced blood clots.

The CDC says the small clot risk can be handled by including warnings to assist younger women in determining if they should take the one-dose shot or take an alternative shot.

These numbers are out of almost 7 million Johnson & Johnson shots administered.

Categories: Coronavirus, Coronavirus Cases, Coronavirus Support